GB0423562D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB0423562D0
GB0423562D0 GB0423562A GB0423562A GB0423562D0 GB 0423562 D0 GB0423562 D0 GB 0423562D0 GB 0423562 A GB0423562 A GB 0423562A GB 0423562 A GB0423562 A GB 0423562A GB 0423562 D0 GB0423562 D0 GB 0423562D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0423562A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Priority to GB0423562A priority Critical patent/GB0423562D0/en
Publication of GB0423562D0 publication Critical patent/GB0423562D0/en
Priority to PL05707363T priority patent/PL1781657T3/en
Priority to DK05707363.7T priority patent/DK1781657T3/en
Priority to EP05707363A priority patent/EP1781657B1/en
Priority to KR1020067016277A priority patent/KR101100601B1/en
Priority to NZ548496A priority patent/NZ548496A/en
Priority to PCT/EP2005/001449 priority patent/WO2005077950A2/en
Priority to CN2010102007350A priority patent/CN101863888B/en
Priority to BRPI0507604-8A priority patent/BRPI0507604A/en
Priority to PT57073637T priority patent/PT1781657E/en
Priority to CA2556073A priority patent/CA2556073C/en
Priority to AU2005212816A priority patent/AU2005212816C1/en
Priority to RU2006132925/04A priority patent/RU2395511C2/en
Priority to JP2006552565A priority patent/JP5001012B2/en
Priority to SI200531730T priority patent/SI1781657T1/en
Priority to SG200803771-5A priority patent/SG157242A1/en
Priority to CN2005800114336A priority patent/CN101103030B/en
Priority to US10/589,474 priority patent/US7713982B2/en
Priority to ES05707363T priority patent/ES2406732T3/en
Priority to PE2005000170A priority patent/PE20060317A1/en
Priority to ARP050100512A priority patent/AR047669A1/en
Priority to TW094104133A priority patent/TWI350289B/en
Priority to MYPI20050527A priority patent/MY148937A/en
Priority to IL177051A priority patent/IL177051A/en
Priority to MA29262A priority patent/MA28357A1/en
Priority to NO20064151A priority patent/NO337281B1/en
Priority to HK07109621.1A priority patent/HK1104530A1/en
Priority to JP2008030344A priority patent/JP5020848B2/en
Priority to US12/552,649 priority patent/US8394808B2/en
Priority to US12/717,349 priority patent/US8268839B2/en
Priority to US13/760,423 priority patent/US20130150383A1/en
Priority to HRP20130406TT priority patent/HRP20130406T1/en
Priority to CY20131100430T priority patent/CY1114022T1/en
Priority to US14/549,721 priority patent/US20150080418A1/en
Ceased legal-status Critical Current

Links

GB0423562A 2004-02-14 2004-10-22 Novel compounds Ceased GB0423562D0 (en)

Priority Applications (34)

Application Number Priority Date Filing Date Title
GB0423562A GB0423562D0 (en) 2004-10-22 2004-10-22 Novel compounds
CA2556073A CA2556073C (en) 2004-02-14 2005-02-10 8-chloro-1,3-disubstituted xanthine derivatives as hm74a receptor modulators
CN2005800114336A CN101103030B (en) 2004-02-14 2005-02-10 Medicaments with HM74A receptor activity
DK05707363.7T DK1781657T3 (en) 2004-02-14 2005-02-10 MEDICINES WITH HM74A RECEPTOR ACTIVITY
EP05707363A EP1781657B1 (en) 2004-02-14 2005-02-10 Medicaments with hm74a receptor activity
KR1020067016277A KR101100601B1 (en) 2004-02-14 2005-02-10 Novel compounds
US10/589,474 US7713982B2 (en) 2004-02-14 2005-02-10 Xanthines with HM74A receptor activity
PCT/EP2005/001449 WO2005077950A2 (en) 2004-02-14 2005-02-10 Medicaments with hm74a receptor activity
CN2010102007350A CN101863888B (en) 2004-02-14 2005-02-10 Medicaments with HM74a receptor activity
ES05707363T ES2406732T3 (en) 2004-02-14 2005-02-10 Medicines with acitvity of the HM74A receptor
PT57073637T PT1781657E (en) 2004-02-14 2005-02-10 Medicaments with hm74a receptor activity
BRPI0507604-8A BRPI0507604A (en) 2004-02-14 2005-02-10 medicines with hm74a receptor activity
AU2005212816A AU2005212816C1 (en) 2004-02-14 2005-02-10 Novel compounds
RU2006132925/04A RU2395511C2 (en) 2004-02-14 2005-02-10 Novel compounds
JP2006552565A JP5001012B2 (en) 2004-02-14 2005-02-10 Drug having HM74A receptor activity
SI200531730T SI1781657T1 (en) 2004-02-14 2005-02-10 Medicaments with hm74a receptor activity
SG200803771-5A SG157242A1 (en) 2004-02-14 2005-02-10 Medicaments with hm74a receptor agonist activity
PL05707363T PL1781657T3 (en) 2004-02-14 2005-02-10 Medicaments with hm74a receptor activity
NZ548496A NZ548496A (en) 2004-02-14 2005-02-10 Medicaments with HM74A receptor activity for disorder of lipid metabolism
PE2005000170A PE20060317A1 (en) 2004-02-14 2005-02-11 XANTINE DERIVATIVES AS SELECTIVE AGONISTS OF THE NICOTINIC ACID RECEPTOR
ARP050100512A AR047669A1 (en) 2004-02-14 2005-02-14 SELECTED ENTITY BETWEEN A XANTINA COMPOUND AND A PHYSIOLOGICALLY FUNCTIONAL DERIVATIVE OF THE SAME, ITS USE FOR THE MANUFACTURE OF A MEDICINAL PRODUCT, PHARMACEUTICAL FORMULATION AND COMBINATION OF FORMULATIONS THAT UNDERSTAND AND METHOD FOR PREPARATION
TW094104133A TWI350289B (en) 2004-02-14 2005-02-14 Novel compounds
MYPI20050527A MY148937A (en) 2004-02-14 2005-02-14 Medicaments with hm74a receptor activity
IL177051A IL177051A (en) 2004-02-14 2006-07-24 Xanthine derivatives, pharmaceutical formulations comprising same, method for their preparation and use thereof in the preparation of medicaments
MA29262A MA28357A1 (en) 2004-02-14 2006-08-11 COMPOUNDS
NO20064151A NO337281B1 (en) 2004-02-14 2006-09-13 New compounds, their use for the manufacture of a medicament, pharmaceutical formulation and combination
HK07109621.1A HK1104530A1 (en) 2004-02-14 2007-09-04 Medicaments with hm74a receptor activity
JP2008030344A JP5020848B2 (en) 2004-02-14 2008-02-12 Drug having HM74A receptor activity
US12/552,649 US8394808B2 (en) 2004-02-14 2009-09-02 HM74 receptor agonists:xanthine derivatives, corresponding pharmaceutical compositions, treatment methods and processes
US12/717,349 US8268839B2 (en) 2004-02-14 2010-03-04 Compounds
US13/760,423 US20130150383A1 (en) 2004-02-14 2013-02-06 Novel compounds
HRP20130406TT HRP20130406T1 (en) 2004-02-14 2013-05-08 Medicaments with hm74a receptor activity
CY20131100430T CY1114022T1 (en) 2004-02-14 2013-05-29 MEDICATIONS WITH HM74A RECEPTOR ACTION
US14/549,721 US20150080418A1 (en) 2004-02-14 2014-11-21 Novel compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0423562A GB0423562D0 (en) 2004-10-22 2004-10-22 Novel compounds

Publications (1)

Publication Number Publication Date
GB0423562D0 true GB0423562D0 (en) 2004-11-24

Family

ID=33485083

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0423562A Ceased GB0423562D0 (en) 2004-02-14 2004-10-22 Novel compounds

Country Status (1)

Country Link
GB (1) GB0423562D0 (en)

Similar Documents

Publication Publication Date Title
GB0400812D0 (en) Novel compounds
EP1718638A4 (en) Novel compounds
GB0409744D0 (en) Novel compounds
GB0405628D0 (en) Novel compounds
GB0402140D0 (en) Novel compounds
GB0402496D0 (en) Novel compounds
GB0402357D0 (en) Novel compounds
EP1805132A4 (en) Novel compounds
EP1796793A4 (en) Novel compounds
GB0408083D0 (en) Novel compounds
GB0402812D0 (en) Novel compounds
GB0402355D0 (en) Novel compounds
GB0402356D0 (en) Novel compounds
GB0404105D0 (en) Novel compounds
GB0402380D0 (en) Novel compounds
GB0402110D0 (en) Novel compounds
GB0404579D0 (en) Novel compounds
GB0402142D0 (en) Novel compounds
GB0402144D0 (en) Novel compounds
GB0402145D0 (en) Novel compounds
GB0402115D0 (en) Novel compounds
GB0402114D0 (en) Novel compounds
GB0423562D0 (en) Novel compounds
GB0401727D0 (en) Novel compounds
GB0400901D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)